NHS Innovation Expo, Manchester
Euformatics exposes at stand 49 (Team Finland) at the NHS Innovation Expo in Manchester, September
Euformatics exposes at stand 49 (Team Finland) at the NHS Innovation Expo in Manchester, September
From Next-Generation Sequencing to Translational Medicine in Neurological Disease Research Identifying disease-causing genes represents a major
Next-generation sequencing, with other technologies, is enabling the emergence of nucleic acid -based testing in the clinical lab. The article in
Euformatics and BC Platforms are to deliver the Public Health Genomics Program at Monash University a system to develop and improve methods for
Euformatics’ partners EMQN and UK NEQAS for Molecular Genetics are currently developing the 2016 quality assessment, which NGS labs will be able
This ELIXIR EXCELERATE course, organised by CSC, covers several aspects of variant analysis including variant annotation and prioritisation.
The team from UK NEQAS for Molecular Genetics and the European Molecular Genetics Quality Network EMQN visited Euformatics to prepare for this
Evidencing the quality of clinical service next-generation sequencing for germline and somatic variants.
![]()

